• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.60% Nasdaq Down 0.46%

    Alimera Sciences, Inc. (ALIM)

    -NasdaqGM
    5.40 Down 0.11(2.00%) 10:40AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:5.51
    Open:5.46
    Bid:5.42 x 700
    Ask:5.45 x 400
    1y Target Est:11.00
    Beta:2.98
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:5.34 - 5.59
    52wk Range:4.58 - 8.36
    Volume:17,901
    Avg Vol (3m):218,953
    Market Cap:239.20M
    P/E (ttm):N/A
    EPS (ttm):-1.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALIM

    Comparison

    Symbol% ChgMkt Cap
    ALIMDown 2.00%239.20M
    AGNDown 1.14%65.50B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):32.04
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.80
    Quarterly EPS Est (Dec-14) :-0.17
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alimera Sciences, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback